Augmedix Insiders
Augmedix employs about 1.4 K people. The company is managed by 10 executives with a total tenure of roughly 3337 years, averaging almost 333.0 years of service per executive, having 143.0 employees per reported executive. Break down of Augmedix's management performance can provide insight into the company performance.
Augmedix |
Augmedix Management Team Effectiveness
The company has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2978) %, meaning that it created substantial loss on money invested by shareholders. Augmedix's management efficiency ratios could be used to measure how well Augmedix manages its routine affairs as well as how well it operates its assets and liabilities.Augmedix Workforce Comparison
Augmedix is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,668. Augmedix totals roughly 1,430 in number of employees claiming about 86% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64. Augmedix Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Augmedix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Augmedix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Augmedix insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ian Shakil over six months ago Disposition of 31994 shares by Ian Shakil of Augmedix at 0.64 subject to Rule 16b-3 | ||
Mcgraw Laurie over six months ago Disposition of 21598 shares by Mcgraw Laurie of Augmedix subject to Rule 16b-3 | ||
Emmanuel Krakaris over six months ago Disposition of 3525 shares by Emmanuel Krakaris of Augmedix at 2.27 subject to Rule 16b-3 | ||
Ian Shakil over six months ago Disposition of 17186 shares by Ian Shakil of Augmedix at 0.86 subject to Rule 16b-3 | ||
Traylor Margie L. over six months ago Acquisition by Traylor Margie L. of 1322 shares of Augmedix subject to Rule 16b-3 | ||
Febbo William J over six months ago Disposition of 21598 shares by Febbo William J of Augmedix subject to Rule 16b-3 | ||
Redmile Group, Llc over six months ago Acquisition by Redmile Group, Llc of 12879 shares of Augmedix subject to Rule 16b-3 | ||
Sandra Breber over six months ago Acquisition by Sandra Breber of 6250 shares of Augmedix subject to Rule 16b-3 |
Augmedix Notable Stakeholders
An Augmedix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Augmedix often face trade-offs trying to please all of them. Augmedix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Augmedix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Emmanuel Krakaris | CEO and President | Profile | |
| Saurav Chatterjee | Chief Officer | Profile | |
| Todd Holvick | Head Compliance | Profile | |
| Jonathan Hawkins | Chief Officer | Profile | |
| Tomer Levy | Senior Engineering | Profile | |
| Lia Wallick | Head People | Profile | |
| Davin MD | Chief Officer | Profile | |
| Ian Shakil | Chief Founder | Profile | |
| Paul Ginocchio | Chief Officer | Profile | |
| Sandra Breber | Chief Officer | Profile |
Augmedix Workforce Analysis
Traditionally, organizations such as Augmedix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Augmedix within its industry.Augmedix Manpower Efficiency
Return on Augmedix Manpower
| Revenue Per Employee | 31.4K | |
| Revenue Per Executive | 4.5M | |
| Net Loss Per Employee | 13.4K | |
| Net Loss Per Executive | 1.9M | |
| Working Capital Per Employee | 23.2K | |
| Working Capital Per Executive | 3.3M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |